Management of fractures in hemophilia

Lawrence Wolff, E. W. Lovrien

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Nine patients with hemophilia A suffered 16 fractures. Four patients had severe hemophilia (factor VIII <1%) and five had moderate or mild hemophilia (factor VIII between 4% and 25%). Two patients developed skeletal pseudotumors after their fractures. One patient developed neurapraxia. Fractures in hemophiliacs should be treated promptly with 25 units/kg/day of factor. Fractures of the upper limb should be maintained at this dose for seven days; lower extremity fractures should be treated with factor for 14 days. Orthopedic management should be the same as used for nonhemophiliacs. Skeletal pseudotumors should be managed with prolonged factor administration and immobilization until radiographic evidence of healing occurs.

Original languageEnglish (US)
Pages (from-to)431-436
Number of pages6
JournalPediatrics
Volume70
Issue number3
StatePublished - 1982

Fingerprint

Hemophilia A
Factor VIII
Upper Extremity
Immobilization
Orthopedics
Lower Extremity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)
  • Arts and Humanities (miscellaneous)

Cite this

Wolff, L., & Lovrien, E. W. (1982). Management of fractures in hemophilia. Pediatrics, 70(3), 431-436.

Management of fractures in hemophilia. / Wolff, Lawrence; Lovrien, E. W.

In: Pediatrics, Vol. 70, No. 3, 1982, p. 431-436.

Research output: Contribution to journalArticle

Wolff, L & Lovrien, EW 1982, 'Management of fractures in hemophilia', Pediatrics, vol. 70, no. 3, pp. 431-436.
Wolff L, Lovrien EW. Management of fractures in hemophilia. Pediatrics. 1982;70(3):431-436.
Wolff, Lawrence ; Lovrien, E. W. / Management of fractures in hemophilia. In: Pediatrics. 1982 ; Vol. 70, No. 3. pp. 431-436.
@article{e885dfa6af5d4b819956c236edec7f73,
title = "Management of fractures in hemophilia",
abstract = "Nine patients with hemophilia A suffered 16 fractures. Four patients had severe hemophilia (factor VIII <1{\%}) and five had moderate or mild hemophilia (factor VIII between 4{\%} and 25{\%}). Two patients developed skeletal pseudotumors after their fractures. One patient developed neurapraxia. Fractures in hemophiliacs should be treated promptly with 25 units/kg/day of factor. Fractures of the upper limb should be maintained at this dose for seven days; lower extremity fractures should be treated with factor for 14 days. Orthopedic management should be the same as used for nonhemophiliacs. Skeletal pseudotumors should be managed with prolonged factor administration and immobilization until radiographic evidence of healing occurs.",
author = "Lawrence Wolff and Lovrien, {E. W.}",
year = "1982",
language = "English (US)",
volume = "70",
pages = "431--436",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "3",

}

TY - JOUR

T1 - Management of fractures in hemophilia

AU - Wolff, Lawrence

AU - Lovrien, E. W.

PY - 1982

Y1 - 1982

N2 - Nine patients with hemophilia A suffered 16 fractures. Four patients had severe hemophilia (factor VIII <1%) and five had moderate or mild hemophilia (factor VIII between 4% and 25%). Two patients developed skeletal pseudotumors after their fractures. One patient developed neurapraxia. Fractures in hemophiliacs should be treated promptly with 25 units/kg/day of factor. Fractures of the upper limb should be maintained at this dose for seven days; lower extremity fractures should be treated with factor for 14 days. Orthopedic management should be the same as used for nonhemophiliacs. Skeletal pseudotumors should be managed with prolonged factor administration and immobilization until radiographic evidence of healing occurs.

AB - Nine patients with hemophilia A suffered 16 fractures. Four patients had severe hemophilia (factor VIII <1%) and five had moderate or mild hemophilia (factor VIII between 4% and 25%). Two patients developed skeletal pseudotumors after their fractures. One patient developed neurapraxia. Fractures in hemophiliacs should be treated promptly with 25 units/kg/day of factor. Fractures of the upper limb should be maintained at this dose for seven days; lower extremity fractures should be treated with factor for 14 days. Orthopedic management should be the same as used for nonhemophiliacs. Skeletal pseudotumors should be managed with prolonged factor administration and immobilization until radiographic evidence of healing occurs.

UR - http://www.scopus.com/inward/record.url?scp=0019962385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019962385&partnerID=8YFLogxK

M3 - Article

C2 - 6810299

AN - SCOPUS:0019962385

VL - 70

SP - 431

EP - 436

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -